US Stock MarketDetailed Quotes
PMCB PharmaCyte Biotech
- 2.110
- -0.010-0.47%
Close Apr 26 16:00 ET
17.84MMarket Cap-1425P/E (TTM)
2.120High2.080Low5.64KVolume2.080Open2.120Pre Close11.85KTurnover0.07%Turnover RatioLossP/E (Static)8.45MShares3.23052wk High0.57P/B17.01MFloat Cap1.92052wk Low--Dividend TTM8.06MShs Float9.980Historical High--Div YieldTTM1.88%Amplitude1.790Historical Low2.099Avg Price1Lot Size
About PharmaCyte Biotech Company
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.
Company Profile
SymbolPMCB
Company NamePharmaCyte Biotech
Listing DateAug 10, 2021
Founded1996
CEOMr. Joshua Nathaniel Silverman
MarketNASDAQ
Employees2
Securities TypeOrdinary Shares
Fiscal Year Ends04-30
Address3960 Howard Hughes Parkway,Suite 500
CityLas Vegas
ProvinceNevada
CountryUnited States of America
Zip Code89169
Phone1-917-595-2850
Websitehttp://pharmacyte.com
Company Executives
- Name
- Position
- Salary
- Joshua Nathaniel Silverman
- Interim Chairman of the Board, Interim Chief Executive Officer and Interim President
- 197.92K
- Carlos Trujillo
- Chief Financial Officer and Principal Accounting Officer
- 385.26K
- Wayne R. Walker
- Independent Director
- 12.50K
- Michael M. Abecassis
- Independent Director
- 38.80K
- Robert Weinstein
- Independent Director
- 18.75K
- Jonathan L. Schechter
- Independent Director
- 31.25K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg